Google
CNTB — CONNECT BIOPHARMA HOLDINGS LTD (Healthcare >> Biotechnology)
CNTB FAQ
What is CNTB's ROE?
CONNECT BIOPHARMA HOLDINGS LTD reports a Return on Equity (ROE) of -151.58%.
What is CNTB's dividend yield?
CONNECT BIOPHARMA HOLDINGS LTD offers a dividend yield of 0.00%.
What is CNTB's Deepscope Quality Score?
Deepscope rates CNTB's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CNTB?
Deepscope's AI Timing Score for CNTB is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CNTB belong to?
CONNECT BIOPHARMA HOLDINGS LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 2.30
Price
0.07
(3.14%)
Day Change
|
|
|---|
CNTB, the overall quality is not good ( Quality = 15) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 91 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 2.30 |
| PBV / Sector |
3.18 / 4.58
|
| Earning Per Share | -1.10 |
| PE / Sector |
N/A / 17.10
|
| PEG or PE/Growth / Sector |
N/A / 0.52
|
| Average 1M Daily Value |
0.48 M
GREAT
|
| Average 1W Daily Value |
0.65 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
47% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:11:34 |
| Symbol | CNTB |
| Name | CONNECT BIOPHARMA HOLDINGS LTD |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 62.96 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 135.37 / 8,655.90 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 3580 Carmel Mountain Road, San Diego, CA, United States, 92130
Phone: 877 245 2787
Website: https://www.connectbiopharm.com
Employees: 64
Sector: Healthcare >> Biotechnology
Description: Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
